New quality, context, and ecosystem capabilities provide enterprises with the tools to confidently deploy AI at scale.

The CD19 inhibitors market is projected to expand substantially in the coming years. This growth is driven by a rising number of patients diagnosed with conditions such as NHL, ALL, NMOSD, IgG4-RD, ...